Skip to content

Effects of remote ischemic conditioning on near and long term outcomes in patients undergoing aortic surgery: a randomized, controlled, double-blind trial

Effects of remote ischemic conditioning on near and long term outcomes in patients undergoing aortic surgery: a randomized, controlled, double-blind trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088830
Enrollment
Unknown
Registered
2024-08-27
Start date
2024-07-02
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic disease

Interventions

Experimental group:After induction of anesthesia and after aortic opening, remote ischemic preconditioning and posttreatment were performed respectively: the cuff was placed on the patients right uppe
Control group:Remote ischemia treatment was performed after anesthesia induction and after aortic opening respectively: the cuff was placed on the patients right upper limb, and 5 minutes of ischemia

Sponsors

Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Over 18 years of age; 2) Patients undergoing elective or emergency aortic surgery; 3) Sign a written informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1) Under 18 years of age; 2) Symptomatic upper limb atherosclerosis, previous upper limb venous thrombosis, or history of axillary vascular surgery; 3) lactation or pregnancy; 4) Cardiac arrest on admission; 5) Severe liver dysfunction (international normalized ratio > 2); 6) History of malignant tumor; 7) Severe lung disease (predicted forced expiratory volume < 40% in 1 second), preoperative respiratory infection; 8) Previous renal failure, history of renal transplantation, and preoperative estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2; 9) Take glibenclamide or nicordil, as these drugs may interfere with RIPC; 10) Previous cerebral infarction, residual limb movement disorder, brain trauma, neurosurgery history 11) History of schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis or dementia; 12) Being recruited into another study that could affect this study; 13) Those with other conditions deemed unsuitable for inclusion by the researchers.

Design outcomes

Primary

MeasureTime frame
All-cause mortality during hospitalization;

Secondary

MeasureTime frame
Myocardial infarction;Neurocognitive dysfunction;Pulmonary infection;Acute kidney injury;Mechanical circulation aid;

Countries

China

Contacts

Public ContactChunmei Xie

Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences

xie1367878@163.com+86 136 7878 2428

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026